• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA OVATION PRIME; MAIN BODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX SANTA ROSA OVATION PRIME; MAIN BODY Back to Search Results
Model Number TV-AB2680-E
Medical Device Problem Code Appropriate Device Problem Term/Code Not Available (3191)
Health Effect - Clinical Codes Aneurysm (1708); Failure of Implant (1924); Stenosis (2263)
Date of Event 09/28/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Devices remain implanted.
 
Event or Problem Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with implant of the ovation prime abdominal aortic aneurysm stent system.Approximately six and a half (6.5) years post initial procedure, the patient presented at routine follow-up with aneurysm enlargement (unknown diameter) and a type iii endoleak at the juncture of the iliac limb and leg to the main body.It is unknown whether the endoleak is a type iiia or iiib, or if the physician plans to re-intervene.The patient is reportedly in stable condition.
 
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the reported endoleak (at indeterminate origin) is confirmed.The reported aneurysm sac growth is unconfirmed.This is moderately consistent with the reported adverse event/incident.The clinical evaluation also shows reasonable evidence to suggest proximal stenosis (of the right common iliac stent) and a non-device-related type ii endoleak (of the lumbar artery) occurred that were not in the event as reported.It is unclear if the type ii endoleak was persistent.These findings were discovered during an examination of ct scans dated (b)(6) 2022 and (b)(6) 2016.Procedure-related harms, device, user, procedure, or anatomy relatedness of this event could not be determined with the medical records available for review.The final patient status was reported as being stable.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Corrections: b5 describe event or problem g3 awareness date h6 investigation finding codes; remove 3233 h6 investigation conclusion codes; remove 11.
 
Event or Problem Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with implant of the ovation prime abdominal aortic aneurysm stent system.Approximately six and a half (6.5) years post initial procedure, the patient presented at routine follow-up with aneurysm enlargement (unknown diameter) and a type iii endoleak at the juncture of the iliac limb and leg to the main body.It is unknown whether the endoleak is a type iiia or iiib, or if the physician plans to re-intervene.The patient is reportedly in stable condition.Additional information: clinical assessment confirmed that proximal stenosis of the right common iliac stent and a type ii endoleak (non-device-related) were also present.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION PRIME
Common Device Name
MAIN BODY
Manufacturer (Section D)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
santa rosa CA 95403
Manufacturer (Section G)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
,
santa rosa CA 95403
Manufacturer Contact
gary kirchgater
3910 brickway blvd
,
santa rosa, CA 95403
8009832284
MDR Report Key15577601
Report Number3008011247-2022-00127
Device Sequence Number7272152
Product Code MIH
UDI-Device IdentifierM701TVAB2680E1
UDI-Public+M701TVAB2680E1/$$3180811FS05011515/
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Health Professional,Company Representative
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 10/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/11/2018
Device Model NumberTV-AB2680-E
Device Catalogue NumberTV-AB2680-E
Device Lot NumberFS050115-15
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/04/2022
Supplement Date Received by Manufacturer11/29/2022
Initial Report FDA Received Date10/11/2022
Supplement Report FDA Received Date12/20/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/09/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
OVATION IX ILIAC LIMB, LN FS031115-32; OVATION IX ILIAC LIMB, LN FS032715-32; OVATION PRIME FILL POLYMER, LN FF110515-02
Outcome Attributed to Adverse Event Other;
Patient Age73 YR
Patient SexUnknown
-
-